搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 小时
DexCom Inc. stock outperforms competitors on strong trading day
Shares of DexCom Inc. DXCM inched 0.89% higher to $78.41 Monday, on what proved to be an all-around grim trading session for ...
jacobin
3 小时
The Press Is Complicit in America’s Health Care Deaths
Major media outlets are giving wall-to-wall coverage to UnitedHealthcare CEO Brian Thompson’s murder while taking millions in ...
5 小时
Key Takeaways From DexCom Analyst Ratings
In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...
7 小时
BNY Mellon Research Growth Fund, Inc. Q3 2024 Commentary
BNY Mellon Research Growth Fund (Class A at NAV) underperformed its benchmark, the Russell 1000® Growth Index, during the ...
9 小时
DexCom price target raised to $99 from $89 at Canaccord
Canaccord analyst William Plovanic raised the firm’s price target on DexCom (DXCM) to $99 from $89 and keeps a Buy rating on the shares.
来自MSN
9 小时
Should You Continue to Retain Insulet Stock in Your Portfolio Now?
Insulet Corporation’s PODD rapid progress with its strategic imperatives on Omnipod platform is poised to help it grow in the upcoming quarters. The largely untapped diabetes market also presents ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈